Silver Wound Dressings Market by Type and Treatment - Global Industry Analysis and Forecast to 2025

Report Code : HC0673

Skin is an organ which protects the body from the external factors such as bacteria and viruses. Lacerations, surgical wounds, cuts and burns are skin injuries. Laceration is a  wound that is produced by tearing of tissue or skin. Laceration can be short or long, wide or narrow and deep or shallow. The cause of laceration is object hitting the skin. Surgical wound is a cut made by a cutting instrument during  surgery. Surgical wounds are of different sizes and they are made in sterile environment. They are either closed or left open to heal. The signs and symptoms of surgical wounds are fever, redness, swelling and increased pain at infected area. There are four classes of surgical wounds, namely, class I, class II, class III, and class IV. Class I wounds are clean wounds which show no indications of inflammation or infection. They involve vascular system or skin. Class II wounds are clean contaminated wounds. They involve respiratory and gastrointestinal wounds. Class III wounds are contaminated wound and arise due to outside objects coming in contact with the wound. Class IV wounds are dirty contaminated wounds. They involve wounds exposed to fecal matter. Cut is another skin injury, which is a closed or an open wound on the skin. Cuts can be caused by sharp objects tearing the skin tissue. Burns are injuries to the skin caused by sunlight, radiation, or any form of heat. Symptoms of burns are large blisters, redness , and swelling.

Dressing is an important part in managing wounds. Silver is used in these dressings due its broad-spectrum antimicrobial property. Silver dressings are made of hydrofibre or foam. Silver wound dressings are used in cuts, surgical wounds, burns and lacerations. The silver wound dressing decreases the bioburden in chronic or acute wounds. Silver found in dressings is in the form of an organic complex, elemental silver or as an inorganic compound. Silver cannot kill bacteria in its unreactive metallic form and ionization of silver is necessary. The external surface of the dressing is coated with silver or it is mixed in the composite before molding. A continuous film is formed on the dressing matrix due to silver ions solution. Silver shows its antimicrobial action when it comes in contact with the wound. Silver affects at various sites and interferes with the cell metabolism. Silver destroys the bacterial cell wall and lead to bacterial cell death.

The major factor responsible for the growth of silver wound dressings market is the increase in prevalence of diabetes. According to IDF, in 2015, diabetes affected 415 million people worldwide. This number is expected to reach up to 642 million by 2040. Further, the rise in the geriatric population will fuel the growth of this market. According to WHO, in 2015, 900 million people were 60 years of age or older and this number is expected to reach up to 2 billion by 2050. Moreover, increase in the incidence of ulcers will further boost the growth of this market. However, the high cost of development and lack of efficacy of silver wound dressing can hamper the growth of silver wound dressings market.

The key strategy followed by major players in the silver wound dressings market is product extension to gain more market share. For instance, in September 2016, ConvaTec Group launched AQUACEL Ag Surgical SP dressing in U.S. It is an extension of AQUACEL Ag Surgical cover dressings which helps to minimize the infections at surgical site. By the launch of AQUACEL Ag Surgical SP dressing, ConvaTec Group will gain more market share.

The major market players in the silver wound dressings market are B. Braun Melsungen AG, Smith & Nephew PLC, 3M, Acelity LP, Inc., Medline industries, and ConvaTec Group.

Silver Wound Dressings Market Segmentation:

By Type:

  • Silver Plated Nylon Fiber Dressings
  • Nano Crystalline  Silver Dressings
  • Silver Alginate Dressings
  • Silver Nitrate Dressings
  • Hydrofibre Silver Dressings
  • Others

By Treatment:

  • Burns
  • Lacerations and Cuts
  • Ulcers
  • Surgical Wounds
  • Skin Grafts
  • Others

By Region:

  • North America
  • U.S
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • Australia
  • India
  • South Korea
  • Rest of Asia-Pacific
  • Rest of the World
  • Brazil
  • South Africa
  • Saudi Arabia
  • Turkey
  • United Arab Emirates
  • Others


Research Methodology

We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Data Mining

Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.

Data Collection Matrix

Data Collection Matrix

Supply Side

Demand Side

Primary Data Sources

  • Manufacturers
  • Distributors & Wholesalers
  • GPOs
  • Physicians/Specialist
  • Healthcare Providers
  • Consumers

Secondary Data Sources

  • Annual Reports/SEC Filings/ Investor Presentations/ Press Releases
  • Government/Associations Publications
  • Case Studies
  • Reference Customers


Market Modeling and Forecasting

We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.

  • Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
  • Number of patients for particular device or medical procedure and
  • Repeated use of particular device depending on health and condition of patient
  • Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.

We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.

Data Validation

We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.

Data Triangulation

Industry Analysis

Qualitative Data

Quantitative Data (2017-2025)

  • Market Dynamics (Drivers, Restraints, and Challenges)
  • Industry Trend Analysis
  • Market Opportunities
  • Government Policies and Regulations, Patent Analysis, and Reimbursement Policies
  • Porter’s Five Forces and PESTLE Analysis
  • Key Developments and Competitive Landscape
  • Market Assessment and Forecast
  • Market Assessment and Forecast, By Product
  • Market Assessment and Forecast, By Technology
  • Market Assessment and Forecast, By Application
  • Market Assessment and Forecast, By End User
  • Market Assessment and Forecast, By Region/Country

License Type

For Any Further Assistance